Long-term efficacy of interferon-alpha and ursodeoxycholic acid in treatment of chronic type C hepatitis.
- 1 January 1997
- journal article
- clinical trial
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 42 (7), 1438-1444
- https://doi.org/10.1023/a:1018854424403
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Effect of ursodeoxycholic acid on HCV replication in subtyped chronic hepatitis CDigestive Diseases and Sciences, 1996
- Epidemiological, clinical and therapeutic associations of hepatitis C types in western European patientsJournal of Hepatology, 1996
- Randomized trial comparing three different regimens of alpha-2a-interferon in chronic hepatitis CHepatology, 1995
- Improvement of liver fibrosis in chronic hepatitis C patients treated with natural interferon alphaJournal of Hepatology, 1995
- The effect of ursodeoxycholic acid on serum enzymes and liver histology in patients with chronic active hepatitis: A 12-month double-blind, placebo-controlled trialJournal of Hepatology, 1994
- Long‐term histologic and viral changes in patients with chronic hepatitis C who responded to alpha interferonLiver International, 1994
- Ursodiol in the long-term treatment of chronic hepatitis: a double-blind multicenter clinical trialJournal of Hepatology, 1993
- Treatment of chronic hepatitis C with high-dose interferon ?-2bDigestive Diseases and Sciences, 1993
- Recombinant Interferon Alfa Therapy for Chronic Hepatitis CNew England Journal of Medicine, 1989
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989